Sensorion Provides Update on Hearing Loss Gene Therapies
The company highlights progress in its SENS-501 and GJB2-GT clinical programs, recent financing, and a leadership transition.
Tag: pharmaceuticals
All
Latest
All
Latest
Therapy Targets Ear Bone Health to Restore Genetic Hearing Loss
Researchers have restored hearing in mice with ENPP1 deficiency using a novel bone-targeted enzyme replacement therapy, offering hope for treating hearing loss in patients with this rare and often fatal genetic disorder.
All
Latest
Acousia to Present PROHEARÂ Study on Hearing Loss Treatment for Cancer Patients
The PROHEAR study is a placebo-controlled Phase 2a study investigating the otoprotective efficacy of ACOU085 in patients with testicular cancer undergoing cisplatin-based chemotherapy.
AudiologyNOW! 2016 Highlights the Changing Landscape of Hearing Healthcare
This year’s AudiologyNOW! AAA event, said to be the largest annual gathering of audiologists in the world, attracted 3,408 audiologists and featured a wealth of instructional sessions and workshops at the Phoenix Convention Center.
Read More
Kathleen Campbell Updates ADA Attendees on Otoprotective Agents That Are Currently in or Approaching Clinical Trials
In the General Session of the 2014 Academy of Doctors of Audiology (ADA) Convention held November 6-9, 2014 in Las Vegas, Kathleen Campbell, PhD, of Southern Illinois University School of Medicine, gave an interesting and lively talk on ototoxicity and the role of pharmaceutical agents in hearing loss management and prevention.
Read MoreC&EN Publishes Article on Pharmaceutical Approaches to Hearing Treatment
More pharmaceutical and research companies are developing drugs to treat and prevent hearing loss, according to an April 7 article in Chemical & Engineering News (C&EN).
Read More